54 related articles for article (PubMed ID: 18497965)
21. Aryl hydrocarbon receptor ligands in cancer: friend and foe.
Murray IA; Patterson AD; Perdew GH
Nat Rev Cancer; 2014 Dec; 14(12):801-14. PubMed ID: 25568920
[TBL] [Abstract][Full Text] [Related]
22. Serum levels of hepatocyte growth factor and epiregulin are associated with the prognosis on anti-EGFR antibody treatment in KRAS wild-type metastatic colorectal cancer.
Takahashi N; Yamada Y; Furuta K; Honma Y; Iwasa S; Takashima A; Kato K; Hamaguchi T; Shimada Y
Br J Cancer; 2014 May; 110(11):2716-27. PubMed ID: 24800946
[TBL] [Abstract][Full Text] [Related]
23. Evidence that TSC2 acts as a transcription factor and binds to and represses the promoter of Epiregulin.
Pradhan SA; Rather MI; Tiwari A; Bhat VK; Kumar A
Nucleic Acids Res; 2014 Jun; 42(10):6243-55. PubMed ID: 24748662
[TBL] [Abstract][Full Text] [Related]
24. Epiregulin: roles in normal physiology and cancer.
Riese DJ; Cullum RL
Semin Cell Dev Biol; 2014 Apr; 28():49-56. PubMed ID: 24631357
[TBL] [Abstract][Full Text] [Related]
25. Trafficking of epidermal growth factor receptor ligands in polarized epithelial cells.
Singh B; Coffey RJ
Annu Rev Physiol; 2014; 76():275-300. PubMed ID: 24215440
[TBL] [Abstract][Full Text] [Related]
26. Inhibition of TGF-β and EGF pathway gene expression and migration of oral carcinoma cells by mucosa-associated lymphoid tissue 1.
Ohyama Y; Kawamoto Y; Chiba T; Maeda G; Sakashita H; Imai K
Br J Cancer; 2013 Jul; 109(1):207-14. PubMed ID: 23778523
[TBL] [Abstract][Full Text] [Related]
27. Transformation of polarized epithelial cells by apical mistrafficking of epiregulin.
Singh B; Bogatcheva G; Washington MK; Coffey RJ
Proc Natl Acad Sci U S A; 2013 May; 110(22):8960-5. PubMed ID: 23671122
[TBL] [Abstract][Full Text] [Related]
28. The Ah receptor regulates growth factor expression in head and neck squamous cell carcinoma cell lines.
John K; Lahoti TS; Wagner K; Hughes JM; Perdew GH
Mol Carcinog; 2014 Oct; 53(10):765-76. PubMed ID: 23625689
[TBL] [Abstract][Full Text] [Related]
29. Upregulation of epidermal growth factor receptor 4 in oral leukoplakia.
Kobayashi H; Kumagai K; Gotoh A; Eguchi T; Yamada H; Hamada Y; Suzuki S; Suzuki R
Int J Oral Sci; 2013 Mar; 5(1):14-20. PubMed ID: 23492901
[TBL] [Abstract][Full Text] [Related]
30. Increased telomerase activity and hTERT expression in human salivary gland carcinomas.
Shigeishi H; Sugiyama M; Tahara H; Ono S; Kumar Bhawal U; Okura M; Kogo M; Shinohara M; Shindoh M; Shintani S; Hamakawa H; Takata T; Kamata N
Oncol Lett; 2011 Sep; 2(5):845-850. PubMed ID: 22866138
[TBL] [Abstract][Full Text] [Related]
31. Amphiregulin and Epiregulin mRNA expression in primary colorectal cancer and corresponding liver metastases.
Kuramochi H; Nakajima G; Kaneko Y; Nakamura A; Inoue Y; Yamamoto M; Hayashi K
BMC Cancer; 2012 Mar; 12():88. PubMed ID: 22409860
[TBL] [Abstract][Full Text] [Related]
32. Protein-intrinsic and signaling network-based sources of resistance to EGFR- and ErbB family-targeted therapies in head and neck cancer.
Mehra R; Serebriiskii IG; Dunbrack RL; Robinson MK; Burtness B; Golemis EA
Drug Resist Updat; 2011 Dec; 14(6):260-79. PubMed ID: 21920801
[TBL] [Abstract][Full Text] [Related]
33. Targeting EGFR resistance networks in head and neck cancer.
Ratushny V; Astsaturov I; Burtness BA; Golemis EA; Silverman JS
Cell Signal; 2009 Aug; 21(8):1255-68. PubMed ID: 19258037
[TBL] [Abstract][Full Text] [Related]
34. Increased expression of CENP-H gene in human oral squamous cell carcinomas harboring high-proliferative activity.
Shigeishi H; Higashikawa K; Ono S; Mizuta K; Ninomiya Y; Yoneda S; Taki M; Kamata N
Oncol Rep; 2006 Nov; 16(5):1071-5. PubMed ID: 17016595
[TBL] [Abstract][Full Text] [Related]
35. Increased expression of heparin binding EGF (HB-EGF), amphiregulin, TGF alpha and epiregulin in androgen-independent prostate cancer cell lines.
Tørring N; Jørgensen PE; Sørensen BS; Nexø E
Anticancer Res; 2000; 20(1A):91-5. PubMed ID: 10769639
[TBL] [Abstract][Full Text] [Related]
36. p73 expression for human buccal epithelial dysplasia and squamous cell carcinoma: does it correlate with nodal status of carcinoma and is there a relationship with malignant change of epithelial dysplasia?
Chen YK; Hsue SS; Lin LM
Head Neck; 2004 Nov; 26(11):945-52. PubMed ID: 15390192
[TBL] [Abstract][Full Text] [Related]
37. Epidermal growth factor receptor (EGFR) in oral squamous cell carcinomas: overexpression, localization and therapeutic implications.
Kuttan NA; Bhakthan NM
Indian J Dent Res; 1997; 8(1):9-18. PubMed ID: 9495132
[TBL] [Abstract][Full Text] [Related]
38. Novel function of ovarian growth factors: combined studies by DNA microarray, biochemical and physiological approaches.
Ben-Ami I; Freimann S; Armon L; Dantes A; Ron-El R; Amsterdam A
Mol Hum Reprod; 2006 Jul; 12(7):413-9. PubMed ID: 16714369
[TBL] [Abstract][Full Text] [Related]
39. Expression of epiregulin, a novel epidermal growth factor ligand associated with prognosis in human oral squamous cell carcinomas.
Shigeishi H; Higashikawa K; Hiraoka M; Fujimoto S; Mitani Y; Ohta K; Takechi M; Kamata N
Oncol Rep; 2008 Jun; 19(6):1557-64. PubMed ID: 18497965
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
